View Document Preview and Link
Document Date: 2014-11-05 17:47:20 Open Document File Size: 386,81 KB Share Result on Facebook
City Cincinnati / / Company Administrator Intellectual Property Department Provider Synergies L.L.C. / Lilly / Provider Synergies L.L.C. / Magellan Medicaid Administration Inc. / / / Event FDA Phase / / IndustryTerm testosterone gel and solution / gel products / pharmaceutical / energy / / MedicalCondition orchitis / BPH / testicular infections / mumps / classical androgen deficiency / androgen deficiency / carcinoma / untreated severe obstructive sleep apnea / fatigue / pituitary hypothalamic injury / Hypogonadism / benign prostatic hyperplasia / prostate cancer / Secondary (hypogonadotropic) hypogonadism / gynecomastia / infertility / congestive heart failure / benign prostatic hypertrophy / tumors / disease / prostatic carcinoma / cryptorchidism / stroke / cardiovascular disease / ADVERSE EFFECTS Application Site Reaction Headache Acne / skin irritation / sexual dysfunction / secondary hypogonadism / myocardial infarction / Male hypogonadism / Sleep apnea / testosterone deficiency / Increased Hypertension Gynecomastia Hemoglobin/ Hematocrit / cardiac disease / osteoporosis / irritation / deficiency / testis syndrome / depression / impotence / prostate carcinoma / Klinefelter’s Syndrome / / MedicalTreatment radiation therapy / chemotherapy / radiation / testosterone replacement / Testosterone replacement therapy / / Organization Pharmacy and Therapeutics committee / Androgenic Agents Review Endocrine Society / American Association of Clinical Endocrinologists / Oral administration / FDA / Medicaid Agency / / Position physician / / Product Androgel / triamcinolone / Androderm / methyltestosterone / testosterone enanthate / Testim / testosterone / hydrocortisone / INDICATIONS Drug / / ProvinceOrState Ohio / / Technology radiation / Geriatrics / pharmacokinetics / chemotherapy / / SocialTag